User profiles for R. J. Mehran

Reza Mehran

Professor of Surgery UT MDACC
Verified email at mdanderson.org
Cited by 10230

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

JY Chang, S Senan, MA Paul, RJ Mehran… - The lancet …, 2015 - thelancet.com
Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC)
is lobectomy with mediastinal lymph node dissection or sampling. Stereotactic ablative …

[PDF][PDF] Anatomy of the thoracic duct

H Hematti, RJ Mehran - Thoracic Surgery Clinics, 2011 - pediatricir.com
The thoracic duct is a major anatomic structure of the upper part of abdomen, chest, and the
lower part of the neck. A precise knowledge of the anatomy of the duct is essential in the …

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

…, C Lu, BS Glisson, LA Byers, YY Elamin, RJ Mehran… - Nature medicine, 2021 - nature.com
Ipilimumab improves clinical outcomes when combined with nivolumab in metastatic non-small
cell lung cancer (NSCLC), but its efficacy and impact on the immune microenvironment …

[HTML][HTML] Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

…, J Zhang, F Skoulidis, J Wu, RJ Mehran… - Nature medicine, 2023 - nature.com
Neoadjuvant ipilimumab + nivolumab (Ipi+Nivo) and nivolumab + chemotherapy (Nivo+CT)
induce greater pathologic response rates than CT alone in patients with operable non-small …

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified …

JY Chang, RJ Mehran, L Feng, V Verma, Z Liao… - The Lancet …, 2021 - thelancet.com
Background A previous pooled analysis of the STARS and ROSEL trials showed higher
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early-…

Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non–small-cell lung cancer

…, M Jeter, MK Bucci, MF McAleer, RJ Mehran… - International Journal of …, 2008 - Elsevier
PURPOSE: To evaluate the efficacy and adverse effects of image-guided stereotactic body
radiation therapy (SBRT) in centrally/superiorly located non–small-cell lung cancer (NSCLC). …

Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma

…, SG Swisher, WL Hofstetter, RJ Mehran… - The Annals of thoracic …, 2007 - Elsevier
BACKGROUND: Malignant pleural mesothelioma is a locally aggressive tumor that is usually
fatal. Extrapleural pneumonectomy (EPP) followed by hemithoracic irradiation has shown …

[HTML][HTML] Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer

…, AA Vaporciyan, RJ Mehran… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE Whether dosimetric advantages of proton beam therapy (PBT) translate to improved
clinical outcomes compared with intensity-modulated radiation therapy (IMRT) remains …

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an …

…, V Verma, JW Welsh, AB Chen, M Altan, RJ Mehran… - The Lancet, 2023 - thelancet.com
Background Stereotactic ablative radiotherapy (SABR) is the standard treatment for
medically inoperable early-stage non-small-cell lung cancer (NSCLC), but regional or distant …

Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation

…, NC Ozburn, DM Woods, X Tang, RJ Mehran… - Clinical Cancer …, 2009 - AACR
Purpose: To determine the frequency of estrogen receptor α and β and progesterone receptor
protein immunohistochemical expression in a large set of non–small cell lung carcinoma (…